Li Yamin, Zhou Weimin, Zhao Yanjie, Wang Yanqun, Xie Zhengde, Lou Yongliang, Tan Wenjie
Key Laboratory of Medical Virology, Ministry of Health, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.
Institute of Medical Virology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
PLoS One. 2015 Apr 9;10(4):e0123234. doi: 10.1371/journal.pone.0123234. eCollection 2015.
Human adenoviruses (HAdVs) have been recognised as pathogens that cause a broad spectrum of diseases. The studies on HAdV infection among children with severe acute respiratory infection (SARI) are limited.
To investigate the prevalence, epidemiology, and genotype of HAdV among children with SARI in China.
Nasopharyngeal aspirates (NPAs) or induced sputum (IS) was collected from hospitalised children with SARIs in Beijing (representing Northern China; n = 259) and Zhejiang Province (representing Eastern China; n = 293) from 2007 to 2010. The prevalence of HAdV was screened by polymerase chain reaction (PCR), followed by sequence typing of PCR fragments that targeted the second half of the hexon gene. In addition, co-infection with other human respiratory viruses, related epidemiological profiles and clinical presentations were investigated.
In total, 76 (13.8%) of 552 SARI patients were positive for HAdV, and the infection rates of HAdV in Northern and Eastern China were 20.1% (n = 52) and 8.2% (n = 24), respectively. HAdV co-infection with other respiratory viruses was frequent (infection rates: Northern China, 90.4%; Eastern China, 70.8%). The peak seasons for HAdV-B infection was winter and spring. Additionally, members of multiple species (Human mastadenovirus B, C, D and E) were circulating among paediatric patients with SARI, of which HAdV-B (34/52; 65.4%) and HAdV-C (20/24, 83.3%) were the most predominant in Northern and Eastern China, respectively. These findings provide a benchmark for future epidemiology and prevention strategies for HAdV.
人类腺病毒(HAdVs)已被确认为可引发多种疾病的病原体。关于严重急性呼吸道感染(SARI)患儿中HAdV感染的研究有限。
调查中国SARI患儿中HAdV的流行情况、流行病学特征及基因型。
2007年至2010年期间,从北京(代表中国北方;n = 259)和浙江省(代表中国东部;n = 293)住院的SARI患儿中采集鼻咽抽吸物(NPAs)或诱导痰(IS)。通过聚合酶链反应(PCR)筛查HAdV的流行情况,随后对靶向六邻体基因后半部分的PCR片段进行序列分型。此外,还调查了与其他人类呼吸道病毒的合并感染情况、相关流行病学特征及临床表现。
552例SARI患者中共有76例(13.8%)HAdV检测呈阳性,中国北方和东部HAdV的感染率分别为20.1%(n = 52)和8.2%(n = 24)。HAdV与其他呼吸道病毒的合并感染很常见(感染率:中国北方为90.4%;中国东部为70.8%)。HAdV-B感染的高峰季节为冬季和春季。此外,多种类型(人腺病毒B、C、D和E)在SARI儿科患者中传播,其中HAdV-B(34/52;65.4%)和HAdV-C(20/24,83.3%)分别在中国北方和东部最为常见。这些发现为未来HAdV的流行病学和预防策略提供了基准。